Heidi, a fast-growing healthcare AI company, has officially launched its regional hub in Singapore, marking a significant step in its Southeast Asia strategy. The move follows the company’s recent $65 million Series B funding round led by Point72 Private Investments, strengthening its financial position for global expansion. By choosing Singapore as its regional base, Heidi is aligning itself with one of the most advanced and innovation-focused healthcare ecosystems in Asia.
Strategic Expansion in Southeast Asia
The new Singapore office will serve as Heidi’s regional headquarters for Southeast Asia, signaling a long-term commitment to the region. The company plans to invest up to $8 million over the next two to three years, primarily directed toward building local teams across sales, implementation, and clinical partnerships. Heidi expects to hire an initial 10 to 12 roles in this period, with further headcount growth anticipated as customer demand and regional partnerships expand.
Addressing Singapore’s Healthcare Capacity Challenge
Heidi’s entry comes at a time when Singapore’s healthcare system is under mounting pressure from demographic and workforce trends. By 2030, one in four Singaporeans will be aged 65 or older, while the country operates with roughly one doctor per 343 residents, creating an intensifying capacity challenge. Against this backdrop, AI-enabled productivity tools are increasingly seen as critical to helping clinicians manage higher patient volumes without compromising quality of care.
Role of AI-Powered Clinical Documentation
Heidi’s AI platform is designed to automate clinical documentation, enabling clinicians to focus more on patient interaction and decision-making. The technology transcribes doctor-patient conversations into structured clinical notes, reducing time spent on administrative tasks and improving the consistency of records. In Singapore alone, the platform has already supported nearly 55,000 consultations, underscoring early traction in a sophisticated healthcare market.
Early Adoption and Local Clinician Feedback
Local clinicians are already reporting tangible benefits from using Heidi’s tools in real-world settings. Dr. Thomas Kelly, CEO and co-founder of Heidi, highlighted Singapore as a launchpad for the company’s next phase of innovation in Southeast Asia, citing its supportive ecosystem, deep talent pool, and privacy-conscious initiatives such as the TRUST platform that enable secure data sharing. Separately, seasoned urgent-care clinician Dr. Sanjeev Shanker noted that Heidi improves the detail and quality of his notes, supports conversations in Mandarin, Malay, and Tamil, and gives him more time with patients while enhancing both patient and physician satisfaction.
Global Growth and Investor Support
Heidi’s Singapore launch builds on its rapid global momentum and recent expansion into Hong Kong, reinforcing its position as a cross-market healthcare AI provider. The company’s AI tools currently process more than 2 million patient consultations every week, operating in 110 languages across 116 countries, which reflects its scalability and broad applicability. Heidi has now raised a total of US$96.6 million in funding from investors including Point72 Private Investments, Blackbird Ventures, Headline, and LocalGlobe, capital that will fuel further product development and market expansion.
By establishing a regional hub in Singapore, Heidi is positioning itself at the intersection of AI innovation and pressing healthcare system needs in Southeast Asia. Its focus on automating clinical documentation, combined with strong investor backing and early adoption by clinicians, suggests meaningful potential to relieve capacity constraints and improve patient experiences. As Singapore confronts an aging population and clinician shortages, Heidi’s expansion signals how AI-driven solutions are moving from experimental pilots to core infrastructure in modern healthcare.